Molecules/BASILIXIMAB

BASILIXIMAB

Molecular Identity

AntibodyApprovedFirst approved 1998

Mechanism of action: Interleukin-2 receptor inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

BASILIXIMABCHI-621SDZ-CHI-621SDZCHI621SIMULECT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to BASILIXIMAB

Loading drug network...